NCT06294314 Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace
| NCT ID | NCT06294314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Marshall University |
| Condition | Anterior Cruciate Ligament Rupture |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2024-02-26 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2024-02-26 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information.
Eligibility Criteria
Inclusion Criteria: * INCLUSION CRITERIA: All patients must meet the following criteria: * Patients must be age 14-26 years old. * Skeletally mature patients, with an ACL deficient knee who desire to have ACL reconstructive surgery using autograft augmentation. * Patients must be a tanner stage of 5 and a posteroanterior left hand film x-ray will be obtained to confirm bone age and skeletal maturity * Patients with associated meniscal and chondral pathology (except patients falling into exclusion criteria below) will be included in the study; such pathology will be treated at the time of ACL reconstruction at the discretion of the surgeon, and such pathology and treatment will be recorded. * An understanding of the purpose of the study and providing written informed consent. Exclusion Criteria: * EXCLUSION CRITERIA: * Patients with multi-ligament surgery (MCL, PCL, LCL, PMC, or PLC repair or reconstruction), * Patients who have undergone previous ACL reconstructive surgery. * Patients who are currently pregnant or nursing. * Patients who have a current infection at the operative site. * Any condition or personal issue that the surgeon deems ineffective to the outcome of the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06294314 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 26 Years, studying Anterior Cruciate Ligament Rupture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06294314 currently recruiting?
Yes, NCT06294314 is actively recruiting participants. Contact the research team at doclav@gmail.com for enrollment information.
Where is the NCT06294314 trial being conducted?
This trial is being conducted at Huntington, United States.
Who is sponsoring the NCT06294314 clinical trial?
NCT06294314 is sponsored by Marshall University. The trial plans to enroll 450 participants.